Your browser doesn't support javascript.
loading
Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome.
Wieczorek, Grazyna; Bigaud, Marc; Pfister, Sabina; Ceci, Melanie; McMichael, Katriona; Afatsawo, Catherine; Hamburger, Meike; Texier, Celine; Henry, Maurane; Cojean, Celine; Erard, Marinette; Mamber, Nadja; Rush, James S.
Afiliación
  • Wieczorek G; Department of Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research Basel, Basel, Switzerland.
  • Bigaud M; Department of Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research Basel, Basel, Switzerland.
  • Pfister S; Department of Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research Basel, Basel, Switzerland.
  • Ceci M; Department of Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research Basel, Basel, Switzerland.
  • McMichael K; Department of Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research Basel, Basel, Switzerland.
  • Afatsawo C; Department of Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research Basel, Basel, Switzerland.
  • Hamburger M; Department of Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research Basel, Basel, Switzerland.
  • Texier C; Department of Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research Basel, Basel, Switzerland.
  • Henry M; Department of Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research Basel, Basel, Switzerland.
  • Cojean C; Department of Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research Basel, Basel, Switzerland.
  • Erard M; Department of Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research Basel, Basel, Switzerland.
  • Mamber N; Department of Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research Basel, Basel, Switzerland.
  • Rush JS; Department of Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research Basel, Basel, Switzerland james.rush@novartis.com.
Ann Rheum Dis ; 78(7): 974-978, 2019 07.
Article en En | MEDLINE | ID: mdl-30902822
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos de Histocompatibilidad Clase I / Transducción de Señal / Síndrome de Sjögren / Antígenos de Histocompatibilidad Menor / Ligando de CD40 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Ann Rheum Dis Año: 2019 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos de Histocompatibilidad Clase I / Transducción de Señal / Síndrome de Sjögren / Antígenos de Histocompatibilidad Menor / Ligando de CD40 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Ann Rheum Dis Año: 2019 Tipo del documento: Article País de afiliación: Suiza